![Incidence of chemotherapy‐induced neutropenia and current practice of prophylaxis with granulocyte colony‐stimulating factors in cancer patients in Spain: a prospective, observational study - Jolis - 2013 - European Journal of Cancer Care - Incidence of chemotherapy‐induced neutropenia and current practice of prophylaxis with granulocyte colony‐stimulating factors in cancer patients in Spain: a prospective, observational study - Jolis - 2013 - European Journal of Cancer Care -](https://onlinelibrary.wiley.com/cms/asset/b8d9d66d-df7e-48d0-af88-526b2d5fae56/ecc12057-fig-0002-m.jpg)
Incidence of chemotherapy‐induced neutropenia and current practice of prophylaxis with granulocyte colony‐stimulating factors in cancer patients in Spain: a prospective, observational study - Jolis - 2013 - European Journal of Cancer Care -
![Día internacional de la lucha contra el cáncer de mama Salomón Menjón: "La vida sana y activa es la mejor vacuna para prevenir el cáncer" Día internacional de la lucha contra el cáncer de mama Salomón Menjón: "La vida sana y activa es la mejor vacuna para prevenir el cáncer"](https://www.diariodesevilla.es/2020/10/16/salud/doctor-Menjon-Clinica-Vithas_1510959551_126905626_667x386.jpg)
Día internacional de la lucha contra el cáncer de mama Salomón Menjón: "La vida sana y activa es la mejor vacuna para prevenir el cáncer"
![Incidence of chemotherapy‐induced neutropenia and current practice of prophylaxis with granulocyte colony‐stimulating factors in cancer patients in Spain: a prospective, observational study - Jolis - 2013 - European Journal of Cancer Care - Incidence of chemotherapy‐induced neutropenia and current practice of prophylaxis with granulocyte colony‐stimulating factors in cancer patients in Spain: a prospective, observational study - Jolis - 2013 - European Journal of Cancer Care -](https://onlinelibrary.wiley.com/cms/asset/d6953734-a396-4af0-a383-9c343147151a/ecc.2013.22.issue-4.cover.jpg?trick=1676094985462)
Incidence of chemotherapy‐induced neutropenia and current practice of prophylaxis with granulocyte colony‐stimulating factors in cancer patients in Spain: a prospective, observational study - Jolis - 2013 - European Journal of Cancer Care -
![Miguel Ángel HERNÁNDEZ | Senior Researcher | Prof. Dr. | Servicio Andaluz de Salud, Sevilla | SAS | Pharmacy | Research profile Miguel Ángel HERNÁNDEZ | Senior Researcher | Prof. Dr. | Servicio Andaluz de Salud, Sevilla | SAS | Pharmacy | Research profile](https://i1.rgstatic.net/ii/profile.image/417372457455616-1476520756079_Q512/Miguel-Angel-Hernandez.jpg)